3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostate Adenocarcinoma
1
Interventions
atezolizumab
1
PROSTVAC
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Prostate Adenocarcinoma
×
PROSTVAC
×
Clear all
NCT04020094
2021-09-22
AtezoVax
University of Utah
Phase 2
Withdrawn